Gyeonggi-do, South Korea

Joo Yun Lee

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Il Dong Pharmaceutical Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joo Yun Lee. Retrieved from https://idiyas.com/inventor/joo-yun-lee-vf5vz7dd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Joo Yun Lee in Acid Secretion Inhibition

Introduction

Joo Yun Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit acid secretion. His work is crucial for advancing treatments related to acid-related disorders.

Latest Patents

Joo Yun Lee holds a patent for an "Acid secretion inhibitor and use thereof." This invention provides a novel compound represented by Chemical Formula 2, or a pharmaceutically acceptable salt thereof. The compound exhibits an excellent acid secretion inhibitory effect, showcasing its potential in therapeutic applications.

Career Highlights

Joo Yun Lee is currently associated with Il Dong Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His role at the company allows him to leverage his expertise in developing innovative solutions for health-related issues.

Collaborations

Some of his notable coworkers include Hong Chul Yoon and Joon Tae Park. Their collaboration contributes to a dynamic work environment that fosters innovation and the development of new pharmaceutical products.

Conclusion

Joo Yun Lee's contributions to the field of acid secretion inhibition highlight his innovative spirit and dedication to improving health outcomes. His work at Il Dong Pharmaceutical Co., Ltd. and his patent for a novel compound are testaments to his impact in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…